Page last updated: 2024-08-24

tirofiban and Purpura, Thrombocytopenic, Idiopathic

tirofiban has been researched along with Purpura, Thrombocytopenic, Idiopathic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, S; Fareed, J; Hoppensteadt, DA; Ma, Q; Messmore, HL; Schultz, CL; Untch, B; Walenga, JM1
Dunkley, S; Evans, S; Gaudry, L; Jepson, N1

Other Studies

2 other study(ies) available for tirofiban and Purpura, Thrombocytopenic, Idiopathic

ArticleYear
Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
    Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Autoantibodies; Blood Platelets; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Macaca mulatta; Models, Animal; Peptides; Phylogeny; Plasmapheresis; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Factor 4; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Serotonin; Species Specificity; Tirofiban; Tyrosine

2002
Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events.
    Platelets, 2005, Volume: 16, Issue:8

    Topics: Acute Disease; Aged; Aged, 80 and over; Autoantibodies; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Tirofiban; Tyrosine

2005